NEW YORK (AP) - Pfizer Inc. said Tuesday that a subsidiary, Explorer
Acquisition Corp., has extended an offer to April 14 for the drug maker to
acquire all of Encysive Pharmaceuticals Inc.'s remaining untendered stock.
Under the tender offer, Explorer Acquisition is offering to buy Encysive's
outstanding shares for $2.35 apiece in cash. Roughly 67.4 million shares, or
about 83.3 percent of the stock, had been tendered by the previous expiration
date on Monday.
Pfizer bought the biopharmaceutical company to strengthen its product
portfolio for treating high blood pressure.
Copyright 2008 Associated Press. All rights reserved. This material may not be
published, broadcast, rewritten, or redistributed.
|